Cargando…
Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers
BACKGROUND: Multidrug resistance (MDR) is one of the major obstacles to successful cancer chemotherapy. Developing efficient strategies to reverse MDR remains a major challenge. Surfactin (SUR), a cyclic lipopeptide biosurfactant, has been found to display anticancer activity. METHODS: In this paper...
Autores principales: | Huang, Wenjing, Lang, Yan, Hakeem, Abdul, Lei, Yan, Gan, Lu, Yang, Xiangliang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868599/ https://www.ncbi.nlm.nih.gov/pubmed/29606866 http://dx.doi.org/10.2147/IJN.S157368 |
Ejemplares similares
-
Folate-mediated mitochondrial targeting with doxorubicin-polyrotaxane nanoparticles overcomes multidrug resistance
por: Wang, He, et al.
Publicado: (2014) -
Polyaspartic acid-anchored mesoporous silica nanoparticles for pH-responsive doxorubicin release
por: Hakeem, Abdul, et al.
Publicado: (2018) -
A composite polymer nanoparticle overcomes multidrug resistance and ameliorates doxorubicin-associated cardiomyopathy
por: Pramanik, Dipankar, et al.
Publicado: (2012) -
Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance
por: Zhao, Yuan, et al.
Publicado: (2016) -
Polysaccharide-based nanoparticles for co-loading mitoxantrone and verapamil to overcome multidrug resistance in breast tumor
por: Xu, Yurui, et al.
Publicado: (2017)